Cargando…

Overexpression of FAM234B Predicts Poor Prognosis in Patients with Luminal Breast Cancer

BACKGROUND: Family with sequence similarity 234 member B (FAM234B), a protein-coding gene, is mainly expressed in brain tissues. Its clinical significance and biological function in tumors, especially in breast cancer (BC), have not been elucidated. METHODS: We firstly investigated the expression pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lyu, Lijuan, Wang, Meng, Zheng, Yi, Tian, Tian, Deng, Yujiao, Xu, Peng, Lin, Shuai, Yang, Si, Zhou, Linghui, Hao, Qian, Wu, Ying, Dai, Zhijun, Kang, Huafeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7721111/ https://www.ncbi.nlm.nih.gov/pubmed/33299353 http://dx.doi.org/10.2147/CMAR.S280009

Ejemplares similares

Overexpression of FAM83A Is Associated with Poor Prognosis of Lung Adenocarcinoma
por: Liu, Xin, et al.
Publicado: (2022)

Effects of Antihypertensive Drugs Use on Risk and Prognosis of Colorectal Cancer: A Meta-Analysis of 37 Observational Studies
por: Deng, Yujiao, et al.
Publicado: (2022)

Overexpressed Pseudogene HLA-DPB2 Promotes Tumor Immune Infiltrates by Regulating HLA-DPB1 and Indicates a Better Prognosis in Breast Cancer
por: Lyu, Lijuan, et al.
Publicado: (2020)

Associations of lncRNA H19 Polymorphisms at MicroRNA Binding Sites with Glioma Susceptibility and Prognosis
por: Deng, Yujiao, et al.
Publicado: (2020)

Combination of SIRT1 and Src overexpression suggests poor prognosis in luminal breast cancer
por: Tan, Jie, et al.
Publicado: (2018)

Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017
por: Li, Na, et al.
Publicado: (2019)

CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer
por: Kwon, Mi Jeong, et al.
Publicado: (2015)

HPV‐related methylation‐based reclassification and risk stratification of cervical cancer
por: Yang, Si, et al.
Publicado: (2020)

miR-499 rs3746444 and miR-196a-2 rs11614913 Are Associated with the Risk of Glioma, but Not the Prognosis
por: Yang, Si, et al.
Publicado: (2020)

Scutellarin inhibits proliferation and invasion of hepatocellular carcinoma cells via down‐regulation of JAK2/STAT3 pathway
por: Liu, Kang, et al.
Publicado: (2019)

GOLGA7 rs11337, a Polymorphism at the MicroRNA Binding Site, Is Associated with Glioma Prognosis
por: Zhou, Linghui, et al.
Publicado: (2019)

Global burden of larynx cancer, 1990-2017: estimates from the global burden of disease 2017 study
por: Deng, Yujiao, et al.
Publicado: (2020)

Associations of CXCL12 polymorphisms with clinicopathological features in breast cancer: a case-control study
por: Lin, Shuai, et al.
Publicado: (2022)

Global, regional, and national burden of Hodgkin lymphoma from 1990 to 2017: estimates from the 2017 Global Burden of Disease study
por: Zhou, Linghui, et al.
Publicado: (2019)

Prognostic Values of LAPTM4B-35 in Human Cancer: A Meta-analysis
por: Zhou, Linghui, et al.
Publicado: (2018)

Effects of Postoperative Radiotherapy in Early Breast Cancer Patients Older than 75 Years: A Propensity-Matched Analysis
por: Zhou, Linghui, et al.
Publicado: (2019)

Overexpression of topoisomerase II alpha protein is a factor for poor prognosis in patients with luminal B breast cancer
por: Shigematsu, Hideo, et al.
Publicado: (2018)

Four common polymorphisms of BRIP1 (rs2048718, rs4988344, rs4986764, and rs6504074) and cancer risk: evidence from 13,716 cancer patients and 15,590 cancer-free controls
por: Liu, Di, et al.
Publicado: (2018)

Genetic polymorphisms of estrogen receptor genes are associated with breast cancer susceptibility in Chinese women
por: Dai, Zhijun, et al.
Publicado: (2019)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

The Effect of Hexavalent Chromium on the Incidence and Mortality of Human Cancers: A Meta-Analysis Based on Published Epidemiological Cohort Studies
por: Deng, Yujiao, et al.
Publicado: (2019)

Regulatory mechanisms, functions, and clinical significance of CircRNAs in triple-negative breast cancer
por: Lyu, Lijuan, et al.
Publicado: (2021)

FAM72 serves as a biomarker of poor prognosis in human lung adenocarcinoma
por: Yu, Yilin, et al.
Publicado: (2021)

Highly expressed FAM189B predicts poor prognosis in hepatocellular carcinoma
por: Ma, Wanshan, et al.
Publicado: (2022)

Identification of lncRNA FAM83H-AS1 as a novel prognostic marker in luminal subtype breast cancer
por: Yang, Fan, et al.
Publicado: (2016)

GPR116 overexpression correlates with poor prognosis in gastric cancer
por: Zheng, Tian, et al.
Publicado: (2021)

Association of two FOXP3 polymorphisms with breast cancer susceptibility in Chinese Han women
por: Tian, Tian, et al.
Publicado: (2018)

Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma
por: Zhang, Xinyuan, et al.
Publicado: (2017)

Fam20C Overexpression Predicts Poor Outcomes and is a Diagnostic Biomarker in Lower-Grade Glioma
por: Feng, Jing, et al.
Publicado: (2021)

Overexpression of LRRC59 Is Associated with Poor Prognosis and Promotes Cell Proliferation and Invasion in Lung Adenocarcinoma
por: Li, Dong, et al.
Publicado: (2020)

Overexpressing PLOD Family Genes Predict Poor Prognosis in Pancreatic Cancer
por: Zhang, Jing, et al.
Publicado: (2022)

Global Burden of Thyroid Cancer From 1990 to 2017
por: Deng, YuJiao, et al.
Publicado: (2020)

TRPV4 Overexpression Promotes Metastasis Through Epithelial–Mesenchymal Transition in Gastric Cancer and Correlates with Poor Prognosis
por: Wang, Huafeng, et al.
Publicado: (2020)

Effects of marital status on breast cancer survival by age, race, and hormone receptor status: A population‐based Study
por: Zhai, Zhen, et al.
Publicado: (2019)

Association Between Genetic Polymorphisms In TYMS And Glioma Risk In Chinese Patients: A Case-Control Study
por: Yao, Li, et al.
Publicado: (2019)

Poor prognosis of nucleophosmin overexpression in solid tumors: a meta-analysis
por: Chen, Siying, et al.
Publicado: (2018)

23.4 Briefing
por: LeMaster, Joseph W
Publicado: (2020)

Overexpression of CUEDC2 Predicts Poor Prognosis in Ovarian Serous Carcinomas
por: Wang, Aichun, et al.
Publicado: (2015)

Overexpression of ERCC3 is associated with poor prognosis in patients with pancreatic cancer
por: Wang, Shujie, et al.
Publicado: (2021)

Overexpression of DDX49 in prostate cancer is associated with poor prognosis
por: Tao, Junyue, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rvl396rp1kah4s54bekmi1eghs